Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Arcus Biosciences Inc
(NY:
RCUS
)
14.68
+0.09 (+0.62%)
Official Closing Price
Updated: 7:00 PM EDT, Apr 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
450,974
Open
14.67
Bid (Size)
14.65 (10)
Ask (Size)
14.81 (1)
Prev. Close
14.59
Today's Range
14.51 - 15.19
52wk Range
12.95 - 25.47
Shares Outstanding
75,500,000
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Arcus Biosciences Announces New Employment Inducement Grants
April 09, 2024
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
March 26, 2024
From
Arcus Biosciences
Via
Business Wire
Performance
YTD
-25.41%
-25.41%
1 Month
-10.87%
-10.87%
3 Month
-2.85%
-2.85%
6 Month
-9.27%
-9.27%
1 Year
-23.98%
-23.98%
More News
Read More
Navigating 5 Analyst Ratings For Arcus Biosciences
March 25, 2024
Via
Benzinga
Arcus Biosciences Announces New Employment Inducement Grants
March 11, 2024
From
Arcus Biosciences
Via
Business Wire
Critical Insights From Arcus Biosciences Analyst Ratings: What You Need To Know
February 22, 2024
Via
Benzinga
Recap: Arcus Biosciences Q4 Earnings
February 21, 2024
Via
Benzinga
Arcus Biosciences to Participate in Two Upcoming Investor Conferences
February 28, 2024
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
February 27, 2024
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides a Pipeline Update
February 21, 2024
From
Arcus Biosciences
Via
Business Wire
Earnings Scheduled For February 21, 2024
February 21, 2024
Via
Benzinga
Preview: Arcus Biosciences's Earnings
February 20, 2024
Via
Benzinga
Key Takeaways From Arcus Biosciences Analyst Ratings
January 30, 2024
Via
Benzinga
Arcus Biosciences Announces New Employment Inducement Grants
February 09, 2024
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences to Host Conference Call to Discuss Fourth-Quarter and Full-Year 2023 Financial Results and Pipeline Updates
February 07, 2024
From
Arcus Biosciences
Via
Business Wire
$320M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying
February 01, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
January 30, 2024
Via
InvestorPlace
Pharma Giant Gilead Raises Stake In Cancer-Focused Arcus Biosciences, Stock Soars
January 30, 2024
Via
Benzinga
Gilead and Arcus Announce Amended Collaboration and Equity Investment
January 29, 2024
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
January 26, 2024
From
Arcus Biosciences
Via
Business Wire
Data from a Phase 1b Study of Quemliclustat-Based Regimens Showed Promising Overall Survival in Treatment-Naïve Metastatic Pancreatic Cancer
January 16, 2024
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
December 11, 2023
From
Arcus Biosciences
Via
Business Wire
Exelixis and Arcus Biosciences Announce Clinical Trial Collaboration to Evaluate Zanzalintinib in Combination with AB521 in Patients with Advanced Renal Cell Carcinoma
December 04, 2023
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
November 27, 2023
From
Arcus Biosciences
Via
Business Wire
From laggards to leaders: Small caps on the rise
November 27, 2023
Via
MarketBeat
Arcus Biosciences to Participate in the 6th Annual Evercore ISI HealthCONx Conference
November 14, 2023
From
Arcus Biosciences
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.